VK Gadi, MD, PhD


Department of Medicine, Division of Hematology/Oncology

University of Illinois College of Medicine Chicago

Research Program

Translational Oncology Program (TO)

A physician-scientist, VK Gadi, MD, PhD, is Deputy Director of the University of Illinois Cancer Center. A medical oncologist at UI Health, he specializes in breast cancer, and his laboratory and clinical research also has focused primarily on breast cancer. A Professor and Director of Medical Oncology at the University of Illinois College of Medicine Chicago in the Division of Hematology and Oncology, he joined the University of Illinois Chicago (UIC) in 2020 after 20 years in Seattle at the University of Washington, where he did his postgraduate training, and the Fred Hutchinson Cancer Center. Since coming to Chicago, he has worked to stabilize, expand and diversify the clinical and research workforce focused on solid tumor malignancies in the Cancer Center’s catchment area of Cook County, the second most populous county in the U.S. and one of the most diverse catchment areas in the nation. Working closely with Cancer Center leaders, he continues to lead efforts to identify and recruit novel molecular assets for clinical trials testing from both big pharmaceutical companies and smaller biotechs. His efforts have increased national-level engagement for cooperative group studies and provided access to Cancer Center disease team leaders for clinical trial development opportunities to ensure trials are written to address the needs of diverse patient populations. In collaboration with several groups of investigators and UIC technology transfer, he also is accelerating the process of commercialization of multiple diagnostic and therapeutic intellectual properties to build a sustainable licensing revenue stream to support Cancer Center activities.

“When it comes to the fight against cancer, I believe that every community, family and patient affected by these terrible diseases has the right to have their voice heard to best inform research that is responsive to their needs and to ensure timely access to cancer care without barriers.”


PhD, University of Alabama at Birmingham; MD, University of Alabama at Birmingham

Disease Focus


Research Keywords

Breast Cancer; Immunotherapy; Precision Medicine

Published Research

PubMed Search

Other Link(s)

Department Webpage

Translate »